$MDT

Medtronic Q1 EPS beats at $1.45; analysts raise price targets

Medtronic (MDT) reported Q1 fiscal 2027 adjusted EPS of $1.45, beating estimates by 4.32%. Sales reached $9.756B, up 13.73% YoY. Analysts raised price targets. The company increased its fiscal 2027 guidance and announced strategic investments in robotics and structural heart technologies. Shares rose 1.86% in early trading.

Original reporting
Published Sep 4, 2026, 12:59 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 6:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Medtronic Q1 EPS beats at $1.45; analysts raise price targets — source image
Decision brief

The 30-second read

$MDTBullishHigh
01

Why it matters

The earnings beat and raised outlook are likely to drive short-term price appreciation.

02

Market read

High relevance for traders focused on medtech and healthcare equities.

03

What to watch

Potential supply chain or regulatory risks in new robotics investments.

Relevance 9/10Novelty 9/10Timing: early trading

Background

Medtronic's Q1 earnings beat and guidance raise are the first report of these figures.

Company-level read

Ticker impact

$MDTBullishHigh confidence
Context

Medtronic reported Q1 FY2027 EPS of $1.45 beating estimates and raised FY2027 earnings guidance.

Expected impact

Potential short-term rally as analysts lift price targets.

Evidence & confidence

Beat on earnings and revenue, higher guidance, and analyst target raises indicate bullish sentiment.

Market effects

Medical technology sector may see broader optimism from Medtronic's beat.

U.S. healthcare stocks could benefit.

Limited to Medtronic and related medtech peers.

Counterpoint

If guidance misses future quarters, the rally could be short-lived.

Key entities

  • Medtronic

    Medical technology giant reporting earnings.

Related articles

$MDTMed

Medtronic (MDT) Commits $700 Million To Robotics As 2026 Impact Report Lands

Medtronic (MDT) announced a $700 million investment in its surgical robotics platform, part of a broader shift toward digital health and AI-driven care. The company released its 2026 Impact Report, outlining progress in AI tools, workforce goals, and environmental targets. Management aims to transform Medtronic into a multi-platform medtech group, focusing on robotics, data-driven care, and digital health.

$MDTMed

Medtronic sets MiniMed exchange ratio at 4.5939

Medtronic plc has set the exchange ratio for its offer to swap up to 225,361,295 shares of MiniMed Group, Inc. common stock for its own shares at 4.5939 MiniMed shares per Medtronic share. The exchange is subject to proration if oversubscribed, with Medtronic potentially accepting up to 55,032,401 of its shares. The final ratio was announced on October 7, 2026.

$MDTHighAI 8/10

Medtronic Sets MiniMed Split-Off Exchange Ratio at 4.5939 Upper Limit

Medtronic (MDT) set the final exchange ratio for its split-off of MiniMed (MMED) at 4.5939 shares of MMED for each MDT share. The ratio is at the offer's upper limit, valuing MDT shares at 100% and MMED at 93% of their average prices. The offer expires October 9, 2026, and may be oversubscribed, with proration possible. The exchange is expected to be tax-free for U.S. federal income tax purposes.

$MDTHighAI 8/10

Medtronic sets final exchange ratio for MiniMed split-off

Medtronic (NYSE:MDT) set the final exchange ratio for its offer to swap shares for MiniMed (NASDAQ:MMED) stock at 4.5939. The company will exchange up to 225,361,295 MiniMed shares. If oversubscribed, Medtronic may exchange additional shares without extending the offer. The exchange offer expires at midnight on Friday.